Norris Perne & French LLP Stryker Corp Transaction History

Norris Perne & French LLP

$1.36 Billion
Q3 2024

A detailed history of Norris Perne & French LLP transactions in Stryker Corp stock. As of the latest transaction made, Norris Perne & French LLP holds 2,689 shares of SYK stock, worth $1.03 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,689

Previous 2,689 -0.0%

Holding current value

$1.03 Million

Previous $914,000 6.24%

% of portfolio

0.07%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$293.94 - $358.71 $27,336 - $33,360	93 Added 3.58%	2,689 $962,000
Q4 2023 Jan 22, 2024	BUY	$253.85 - $299.46 $115,755 - $136,553	456 Added 21.31%	2,596 $777,000
Q3 2023 Oct 18, 2023	BUY	$266.54 - $302.43 $37,848 - $42,945	142 Added 7.11%	2,140 $584,000
Q2 2023 Jul 19, 2023	BUY	$271.49 - $305.09 $21,719 - $24,407	80 Added 4.17%	1,998 $609,000
Q1 2023 Apr 20, 2023	SELL	$246.13 - $285.47 $18,459 - $21,410	-75 Reduced 3.76%	1,918 $547,000
Q4 2022 Jan 24, 2023	SELL	$205.51 - $253.93 $71,928 - $88,875	-350 Reduced 14.94%	1,993 $0
Q2 2022 Aug 11, 2022	SELL	$194.09 - $276.37 $63,661 - $90,649	-328 Reduced 12.28%	2,343 $466,000
Q1 2022 Apr 26, 2022	SELL	$245.33 - $277.77 $12,266 - $13,888	-50 Reduced 1.84%	2,671 $714,000
Q4 2021 Jan 26, 2022	SELL	$236.63 - $276.44 $39,043 - $45,612	-165 Reduced 5.72%	2,721 $728,000
Q3 2021 Oct 26, 2021	SELL	$248.9 - $280.09 $497,800 - $560,180	-2,000 Reduced 40.93%	2,886 $761,000
Q2 2021 Jul 20, 2021	SELL	$242.95 - $267.0 $22,594 - $24,831	-93 Reduced 1.87%	4,886 $1.27 Million
Q1 2021 Apr 30, 2021	SELL	$221.01 - $248.82 $963,824 - $1.09 Million	-4,361 Reduced 46.69%	4,979 $1.21 Million
Q4 2020 Jan 27, 2021	SELL	$202.01 - $245.04 $24,241 - $29,404	-120 Reduced 1.27%	9,340 $2.29 Million
Q3 2020 Oct 26, 2020	BUY	$177.77 - $215.81 $13,332 - $16,185	75 Added 0.8%	9,460 $1.97 Million
Q2 2020 Jul 23, 2020	BUY	$144.67 - $207.03 $24,593 - $35,195	170 Added 1.84%	9,385 $1.69 Million
Q1 2020 Apr 16, 2020	SELL	$126.5 - $225.1 $110,687 - $196,962	-875 Reduced 8.67%	9,215 $1.53 Million
Q4 2019 Jan 22, 2020	SELL	$197.98 - $220.53 $959,213 - $1.07 Million	-4,845 Reduced 32.44%	10,090 $2.12 Million
Q3 2019 Oct 24, 2019	SELL	$205.4 - $221.82 $154,050 - $166,365	-750 Reduced 4.78%	14,935 $3.23 Million
Q2 2019 Jul 19, 2019	SELL	$180.24 - $205.58 $34,425 - $39,265	-191 Reduced 1.2%	15,685 $3.22 Million
Q1 2019 Apr 29, 2019	SELL	$152.46 - $198.0 $76,230 - $99,000	-500 Reduced 3.05%	15,876 $3.14 Million
Q4 2018 Jan 28, 2019	SELL	$145.0 - $178.65 $43,500 - $53,595	-300 Reduced 1.8%	16,376 $2.57 Million
Q3 2018 Oct 29, 2018	BUY	$163.25 - $177.68 $18,610 - $20,255	114 Added 0.69%	16,676 $2.96 Million
Q2 2018 Jul 24, 2018	SELL	$155.17 - $179.78 $351,460 - $407,201	-2,265 Reduced 12.03%	16,562 $2.8 Million
Q1 2018 Apr 17, 2018	SELL	$148.01 - $168.91 $58,167 - $66,381	-393 Reduced 2.04%	18,827 $3.03 Million
Q4 2017 Jan 23, 2018	SELL	$143.51 - $159.74 $122,127 - $135,938	-851 Reduced 4.24%	19,220 $2.98 Million
Q3 2017 Nov 01, 2017	BUY	$138.36 - $147.87 $2.78 Million - $2.97 Million	20,071	20,071 $2.85 Million

Others Institutions Holding SYK

# of Institutions

2,228

Shares Held

285M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Stryker Corp Transaction History